We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SCENIHR Recommends Phased Approach to Risk Evaluation of Nanomaterials
SCENIHR Recommends Phased Approach to Risk Evaluation of Nanomaterials
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk to avoid unnecessary testing, an expert committee of the European Commission recommends.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor